16 results on '"Bila R"'
Search Results
2. Structure de Triterpenoides Nouveaux Isoles de Atroxima Afzeliana
- Author
-
R. Huls, Clément Delaude, and Babady‐Bila R. Warin
- Subjects
chemistry.chemical_classification ,Hydrolysis ,Triterpenoid ,Atroxima afzeliana ,chemistry ,Stereochemistry ,visual_art ,Saponin ,visual_art.visual_art_medium ,Bark ,General Chemistry ,Lactone - Abstract
The roots bark saponin of Atroxima afzeliana yields on hydrolysis three new triterpenoids: atroxigenic acid, atroxigenin and atroxigenic acid lactone.
- Published
- 2010
3. Structure de Triterpenoides Nouveaux Isoles de Atroxima Afzeliana
- Author
-
Warin, Babady-Bila R., primary, Delaude, C., additional, and Huls, R., additional
- Published
- 2010
- Full Text
- View/download PDF
4. Laser‐Surface Nanostructures in Carbon Coating
- Author
-
Semchuk, O. Yu., primary, Bila, R. V., additional, Willander, M., additional, and Karlsteen, M., additional
- Published
- 2005
- Full Text
- View/download PDF
5. Laser-induced photoconductivity of ferromagnetic semiconductors.
- Author
-
Semchuk, O. Yu., Bila, R. V., Willander, M., and Karlsteen, M.
- Subjects
- *
PHOTOCONDUCTIVITY , *FERROMAGNETIC materials , *FERROMAGNETISM , *SEMICONDUCTOR lasers , *MAGNONS , *SEMICONDUCTORS - Abstract
The influence of a strong electromagnetic wave on the kinetic phenomena in ferromagnetic semiconductors (FMSC) is considered. To sequentialy consider this influence, we obtained quantum kinetic equations for electrons and magnons involved into the process of electron-magnon interaction at presence of intense high-frequency electromagnetic field. The new mechanism of a photoconduction not bound with a change of the number of carriers in the conduction band of FMSC and hot conduction electrons is offered. The density of electric current in the FMSC provided by strong variable electromagnetic field and feeble constant electric field has been calculated. The valuation of FMSC electric conductivity in the infrared spectral range is made. It is shown that magnification of the amplitude of variable electromagnetic filed results in increasing the conductivity of FMSC at some fixed temperature. [ABSTRACT FROM AUTHOR]
- Published
- 2004
6. USAWC (United States Army War College) Military Studies Program Paper. Petroleum Management in Support of Combat Forces.
- Author
-
ARMY WAR COLL CARLISLE BARRACKS PA, Bila,R V, ARMY WAR COLL CARLISLE BARRACKS PA, and Bila,R V
- Abstract
The paper examines the bulk petroleum distribution system in the CORPS area of operations. Present general support force structure in the CORPS is examined to determine if it would be possible to use its increased productivity to provide both general and direct support to combat formations thereby eliminating the need for the divisional direct support units. The requirement to have highly mobile combat divisions and the ever increasing demand for bulk fuel indicates that petroleum supply points and distribution means must be flexible, redundant, and highly tailorable. The paper concludes that if planned actions to increase the productivity of the petroleum supply company are accomplished that this unit offer sufficient capability to support in a general and direct support role for both light and heavy combat units. Data was gathered from current petroleum and supply manuals, Department of Army productivity plans, and TRADOC briefings.
- Published
- 1985
7. USAWC (United States Army War College) military studies program paper. Petroleum management in support of combat forces. Student essay
- Author
-
Bila, R
- Published
- 1985
8. Adjunctive rosiglitazone treatment for severe pediatric malaria: A randomized placebo-controlled trial in Mozambican children.
- Author
-
Varo R, Crowley VM, Mucasse H, Sitoe A, Bramugy J, Serghides L, Weckman AM, Erice C, Bila R, Vitorino P, Mucasse C, Valente M, Ajanovic S, Balanza N, Zhong K, Derpsch Y, Gladstone M, Mayor A, Bassat Q, and Kain KC
- Subjects
- Humans, Child, Rosiglitazone therapeutic use, Mozambique, Artesunate therapeutic use, Double-Blind Method, Malaria drug therapy, Malaria, Falciparum drug therapy, Antimalarials adverse effects
- Abstract
Objectives: We tested the hypothesis that adjunctive rosiglitazone treatment would reduce levels of circulating angiopoietin-2 (Angpt-2) and improve outcomes of Mozambican children with severe malaria., Methods: A randomized, double-blind, placebo-controlled trial of rosiglitazone vs placebo as adjunctive treatment to artesunate in children with severe malaria was conducted. A 0.045 mg/kg/dose of rosiglitazone or matching placebo were administered, in addition to standard of malaria care, twice a day for 4 days. The primary endpoint was the rate of decline of Angpt-2 over 96 hours. Secondary outcomes included the longitudinal dynamics of angiopoietin-1 (Angpt-1) and the Angpt-2/Angpt-1 ratio over 96 hours, parasite clearance kinetics, clinical outcomes, and safety metrics., Results: Overall, 180 children were enrolled; 91 were assigned to rosiglitazone and 89 to placebo. Children who received rosiglitazone had a steeper rate of decline of Angpt-2 over the first 96 hours of hospitalization compared to children who received placebo; however, the trend was not significant (P = 0.28). A similar non-significant trend was observed for Angpt-1 (P = 0.65) and the Angpt-2/Angpt-1 ratio (P = 0.34). All other secondary and safety outcomes were similar between groups (P >0.05)., Conclusion: Adjunctive rosiglitazone at this dosage was safe and well tolerated but did not significantly affect the longitudinal kinetics of circulating Angpt-2., Competing Interests: Declaration of competing interest The authors do not hold a patent for this indication of rosiglitazone. Rosauro Varo had a fellowship from the program Río Hortega of the Instituto de Salud Carlos III (ISCIII) (CD16/00024) while the study was conducted., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
9. Endothelial transcriptomic analysis identifies biomarkers of severe and cerebral malaria.
- Author
-
Gomes C, Varo R, Duran-Frigola M, Sitoe A, Bila R, Machevo S, Mayor A, Bassat Q, and Rodriguez A
- Subjects
- Humans, Child, Endothelial Cells, Transcriptome, Biomarkers, ADAMTS Proteins, Malaria, Cerebral diagnosis, Malaria, Falciparum diagnosis
- Abstract
Malaria can quickly progress from an uncomplicated infection into a life-threatening severe disease. However, the unspecificity of early symptoms often makes it difficult to identify patients at high risk of developing severe disease. Additionally, one of the most feared malaria complications - cerebral malaria - is challenging to diagnose, often resulting in treatment delays that can lead to adverse outcomes. To identify candidate biomarkers for the prognosis and/or diagnosis of severe and cerebral malaria, we have analyzed the transcriptomic response of human brain microvascular endothelial cells to erythrocytes infected with Plasmodium falciparum. Candidates were validated in plasma samples from a cohort of pediatric patients with malaria from Mozambique, resulting in the identification of several markers with capacity to distinguish uncomplicated from severe malaria, the most potent being the metallopeptidase ADAMTS18. Two other biomarkers, Angiopoietin-like-4 and Inhibin-βE were able to differentiate children with cerebral malaria within the severe malaria group, showing increased sensitivity after combination in a biomarker signature. The validation of the predicted candidate biomarkers in plasma of children with severe and cerebral malaria underscores the power of this transcriptomic approach and indicates that a specific endothelial response to P. falciparum-infected erythrocytes is linked to the pathophysiology of severe malaria.
- Published
- 2023
- Full Text
- View/download PDF
10. Evaluation of the Performance of a 3D-Printed Smartphone-Based Retinal Imaging Device as a Screening Tool for Retinal Pathology in Mozambique.
- Author
-
Varo R, Postigo M, Bila R, Dacal E, Chiconela H, García-Villena J, Cuadrado D, Vladimirov A, Díez N, Vallés-López R, Sitoe A, Vitorino P, Mucasse C, Beltran-Agullo L, Pujol O, García V, Abdala M, Sallé L, Anton A, Santos A, Ledesma-Carbayo MJ, Luengo-Oroz M, and Bassat Q
- Subjects
- Humans, Mozambique epidemiology, Pilot Projects, Mass Screening methods, Printing, Three-Dimensional, Smartphone, Retinal Diseases diagnostic imaging, Retinal Diseases epidemiology
- Abstract
Low-income countries carry approximately 90% of the global burden of visual impairment, and up to 80% of this could be prevented or cured. However, there are only a few studies on the prevalence of retinal disease in these countries. Easier access to retinal information would allow differential diagnosis and promote strategies to improve eye health, which are currently scarce. This pilot study aims to evaluate the functionality and usability of a tele-retinography system for the detection of retinal pathology, based on a low-cost portable retinal scanner, manufactured with 3D printing and controlled by a mobile phone with an application designed ad hoc. The study was conducted at the Manhiça Rural Hospital in Mozambique. General practitioners, with no specific knowledge of ophthalmology or previous use of retinography, performed digital retinographies on 104 hospitalized patients. The retinographies were acquired in video format, uploaded to a web platform, and reviewed centrally by two ophthalmologists, analyzing the image quality and the presence of retinal lesions. In our sample there was a high proportion of exudates and hemorrhages-8% and 4%, respectively. In addition, the presence of lesions was studied in patients with known underlying risk factors for retinal disease, such as HIV, diabetes, and/or hypertension. Our tele-retinography system based on a smartphone coupled with a simple and low-cost 3D printed device is easy to use by healthcare personnel without specialized ophthalmological knowledge and could be applied for the screening and initial diagnosis of retinal pathology.
- Published
- 2023
- Full Text
- View/download PDF
11. Tracking SARS-CoV-2 introductions in Mozambique using pandemic-scale phylogenies: a retrospective observational study.
- Author
-
Martínez-Martínez FJ, Massinga AJ, De Jesus Á, Ernesto RM, Cano-Jiménez P, Chiner-Oms Á, Gómez-Navarro I, Guillot-Fernández M, Guinovart C, Sitoe A, Vubil D, Bila R, Gujamo R, Enosse S, Jiménez-Serrano S, Torres-Puente M, Comas I, Mandomando I, López MG, and Mayor A
- Subjects
- Humans, Pandemics prevention & control, Phylogeny, Mozambique epidemiology, Retrospective Studies, Prospective Studies, SARS-CoV-2 genetics, COVID-19 epidemiology, COVID-19 prevention & control
- Abstract
Background: From the start of the SARS-CoV-2 outbreak, global sequencing efforts have generated an unprecedented amount of genomic data. Nonetheless, unequal sampling between high-income and low-income countries hinders the implementation of genomic surveillance systems at the global and local level. Filling the knowledge gaps of genomic information and understanding pandemic dynamics in low-income countries is essential for public health decision making and to prepare for future pandemics. In this context, we aimed to discover the timing and origin of SARS-CoV-2 variant introductions in Mozambique, taking advantage of pandemic-scale phylogenies., Methods: We did a retrospective, observational study in southern Mozambique. Patients from Manhiça presenting with respiratory symptoms were recruited, and those enrolled in clinical trials were excluded. Data were included from three sources: (1) a prospective hospital-based surveillance study (MozCOVID), recruiting patients living in Manhiça, attending the Manhiça district hospital, and fulfilling the criteria of suspected COVID-19 case according to WHO; (2) symptomatic and asymptomatic individuals with SARS-CoV-2 infection recruited by the National Surveillance system; and (3) sequences from SARS-CoV-2-infected Mozambican cases deposited on the Global Initiative on Sharing Avian Influenza Data database. Positive samples amenable for sequencing were analysed. We used Ultrafast Sample placement on Existing tRees to understand the dynamics of beta and delta waves, using available genomic data. This tool can reconstruct a phylogeny with millions of sequences by efficient sample placement in a tree. We reconstructed a phylogeny (~7·6 million sequences) adding new and publicly available beta and delta sequences., Findings: A total of 5793 patients were recruited between Nov 1, 2020, and Aug 31, 2021. During this time, 133 328 COVID-19 cases were reported in Mozambique. 280 good quality new SARS-CoV-2 sequences were obtained after the inclusion criteria were applied and an additional 652 beta (B.1.351) and delta (B.1.617.2) public sequences were included from Mozambique. We evaluated 373 beta and 559 delta sequences. We identified 187 beta introductions (including 295 sequences), divided in 42 transmission groups and 145 unique introductions, mostly from South Africa, between August, 2020 and July, 2021. For delta, we identified 220 introductions (including 494 sequences), with 49 transmission groups and 171 unique introductions, mostly from the UK, India, and South Africa, between April and November, 2021., Interpretation: The timing and origin of introductions suggests that movement restrictions effectively avoided introductions from non-African countries, but not from surrounding countries. Our results raise questions about the imbalance between the consequences of restrictions and health benefits. This new understanding of pandemic dynamics in Mozambique can be used to inform public health interventions to control the spread of new variants., Funding: European and Developing Countries Clinical Trials, European Research Council, Bill & Melinda Gates Foundation, and Agència de Gestió d'Ajuts Universitaris i de Recerca., Competing Interests: Declaration of interests We declare no competing interests., (Copyright © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
12. Serial lung ultrasounds in pediatric pneumonia in Mozambique and Pakistan.
- Author
-
Ginsburg AS, Nisar I, Madrid L, Lenahan JL, Balouch B, Vitorino P, Hwang J, Lamorte A, Kanth N, Bila R, Valente M, Varo R, May S, Bassat Q, Jehan F, and Volpicelli G
- Subjects
- Female, Follow-Up Studies, Humans, Infant, Longitudinal Studies, Male, Mozambique epidemiology, Pakistan epidemiology, Pilot Projects, Prospective Studies, Ultrasonography methods, Lung diagnostic imaging, Pneumonia diagnostic imaging, Pneumonia epidemiology, Point-of-Care Testing, Thorax diagnostic imaging
- Abstract
Lung ultrasound (LUS) is a promising point-of-care imaging technology for diagnosing and managing pneumonia. We sought to explore serial LUS examinations in children with chest-indrawing pneumonia in resource-constrained settings and compare their clinical and LUS imaging courses longitudinally. We conducted a prospective, observational study among children aged 2 through 23 months with World Health Organization Integrated Management of Childhood Illness chest-indrawing pneumonia and among children without fast breathing, chest indrawing or fever (no pneumonia cohort) at 2 district hospitals in Mozambique and Pakistan. We assessed serial LUS at enrollment, 2, 6, and 14 days, and performed a secondary analysis of enrolled children's longitudinal clinical and imaging courses. By Day 14, the majority of children with chest-indrawing pneumonia and consolidation on enrollment LUS showed improvement on follow-up LUS (100% in Mozambique, 85.4% in Pakistan) and were clinically cured (100% in Mozambique, 78.0% in Pakistan). In our cohort of children with chest-indrawing pneumonia, LUS imaging often reflected the clinical course; however, it is unclear how serial LUS would inform the routine management of non-severe chest-indrawing pneumonia.
- Published
- 2021
- Full Text
- View/download PDF
13. Performance of lung ultrasound in the diagnosis of pediatric pneumonia in Mozambique and Pakistan.
- Author
-
Ginsburg AS, Lenahan JL, Jehan F, Bila R, Lamorte A, Hwang J, Madrid L, Nisar MI, Vitorino P, Kanth N, Balcells R, Baloch B, May S, Valente M, Varo R, Nadeem N, Bassat Q, and Volpicelli G
- Subjects
- Female, Humans, Infant, Male, Mozambique, Pakistan, Radiography, Thoracic, Reproducibility of Results, Ultrasonography, Lung diagnostic imaging, Pneumonia diagnostic imaging
- Abstract
Introduction: Improved pneumonia diagnostics are needed in low-resource settings (LRS); lung ultrasound (LUS) is a promising diagnostic technology for pneumonia. The objective was to compare LUS versus chest radiograph (CXR), and among LUS interpreters, to compare expert versus limited training with respect to interrater reliability., Methods: We conducted a prospective, observational study among children with World Health Organization (WHO) Integrated Management of Childhood Illness (IMCI) chest-indrawing pneumonia at two district hospitals in Mozambique and Pakistan, and assessed LUS and CXR examinations. The primary endpoint was interrater reliability between LUS and CXR interpreters for pneumonia diagnosis among children with WHO IMCI chest-indrawing pneumonia., Results: Interrater reliability was excellent for expert LUS interpreters, but poor to moderate for expert CXR interpreters and onsite LUS interpreters with limited training., Conclusions: Among children with WHO IMCI chest-indrawing pneumonia, expert interpreters may achieve substantially higher interrater reliability for LUS compared to CXR, and LUS showed potential as a preferred reference standard. For point-of-care LUS to be successfully implemented for the diagnosis and management of pneumonia in LRS, the clinical environment and amount of appropriate user training will need to be understood and addressed., (© 2020 The Authors. Pediatric Pulmonology published by Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
14. Paraplegia and spinal deformity in a Mozambican child with Pott's disease and tuberculous scrofula.
- Author
-
Varo R, Bila R, Saavedra B, Sitoe A, Uamusse A, Ribó-Aristizabal JL, and García-Basteiro AL
- Subjects
- Abscess microbiology, Antitubercular Agents administration & dosage, Antitubercular Agents therapeutic use, Child, Preschool, Humans, Male, Mycobacterium tuberculosis isolation & purification, Neck microbiology, Neck pathology, Paraplegia diagnosis, Tomography, X-Ray Computed methods, Treatment Outcome, Tuberculosis, Lymph Node pathology, Tuberculosis, Spinal drug therapy, Tuberculosis, Spinal microbiology, Tuberculosis, Spinal pathology, Paraplegia etiology, Tuberculosis, Lymph Node microbiology, Tuberculosis, Spinal diagnostic imaging
- Published
- 2019
- Full Text
- View/download PDF
15. Continuous Glucose Monitoring in Resource-Constrained Settings for Hypoglycaemia Detection: Looking at the Problem from the Other Side of the Coin.
- Author
-
Bila R, Varo R, Madrid L, Sitoe A, and Bassat Q
- Subjects
- Humans, Hypoglycemia pathology, Poverty, Blood Glucose chemistry, Hypoglycemia diagnosis
- Abstract
The appearance, over a decade ago, of continuous glucose monitoring (CGM) devices has triggered a patient-centred revolution in the control and management of diabetes mellitus and other metabolic conditions, improving the patient’s glycaemic control and quality of life. Such devices, the use of which remains typically restricted to high-income countries on account of their elevated costs, at present show very limited implantation in resource-constrained settings, where many other urgent health priorities beyond diabetes prevention and management still need to be resolved. In this commentary, we argue that such devices could have an additional utility in low-income settings, whereby they could be selectively used among severely ill children admitted to hospital for closer monitoring of paediatric hypoglycaemia, a life-threatening condition often complicating severe cases of malaria, malnutrition, and other common paediatric conditions.
- Published
- 2018
- Full Text
- View/download PDF
16. Safety and tolerability of adjunctive rosiglitazone treatment for children with uncomplicated malaria.
- Author
-
Varo R, Crowley VM, Sitoe A, Madrid L, Serghides L, Bila R, Mucavele H, Mayor A, Bassat Q, and Kain KC
- Subjects
- Child, Child, Preschool, Double-Blind Method, Female, Humans, Infant, Male, Mozambique, Rosiglitazone, Antimalarials therapeutic use, Malaria drug therapy, Thiazolidinediones therapeutic use
- Abstract
Background: Despite the widespread use and availability of rapidly acting anti-malarials, the fatality rate of severe malaria in sub-Saharan Africa remains high. Adjunctive therapies that target the host response to malaria infection may further decrease mortality over that of anti-malarial agents alone. Peroxisome proliferator-activated receptor-gamma agonists (e.g. rosiglitazone) have been shown to act on several pathways implicated in the pathogenesis of severe malaria and may improve clinical outcome as an adjunctive intervention., Methods: In this study, the safety and tolerability of adjunctive rosiglitazone in paediatric uncomplicated malaria infection was evaluated in Mozambique, as a prelude to its evaluation in a randomized controlled trial in paediatric severe malaria. The study was a prospective, randomized, double-blind, placebo-controlled, phase IIa trial of rosiglitazone (0.045 mg/kg/dose) twice daily for 4 days versus placebo as adjunctive treatment in addition to Mozambican standard of care (artemisinin combination therapy Coartem
® ) in children with uncomplicated malaria. The primary outcomes were tolerability and safety, including clinical, haematological, biochemical, and electrocardiographic evaluations., Results: Thirty children were enrolled: 20 were assigned to rosiglitazone and 10 to placebo. Rosiglitazone treatment did not induce hypoglycaemia nor significantly alter clinical, biochemical, haematological, or electrocardiographic parameters., Conclusions: Adjunctive rosiglitazone was safe and well-tolerated in children with uncomplicated malaria, permitting the extension of its evaluation as adjunctive therapy for severe malaria. The trial is registered with Clinicaltrials.gov, NCT02694874.- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.